• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Page 8 > Press

Press releases

Page 8 > Press

Press releases

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2026

Results

No results found. Please try using different filter option(s).

Statements
25 Sep 2026

DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly

Viewpoints
30 Sep 2030

How a one-day cure could finally eliminate sleeping sickness in Africa

El Pais logo
In the media
24 Sep 2026

De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia

El País
News
16 Sep 2026

Beyond representation: Building research around women’s realities

News
15 Sep 2026

New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D

The Telegraph
In the media
14 Sep 2026

Asia on high alert as El Niño threatens new dengue epidemic

Swissinfo logo
In the media
9 Sep 2026

Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements

Swissinfo
Hand with lap glove holding a sample with transparent liquid
Publications
8 Sep 2026

Implementing Article 9.5 of the WHO Pandemic Agreement

In the media
30 Sep 2030

Dengue: un essai clinique mondial pour trouver un traitement

the Scientist logo
In the media
31 Aug 2026

Mycetoma: The Invisible Disease Beneath India’s Soil

The Scientist
Stories
27 Aug 2026

Drug discovery explained: Moonshot: open science to prepare for pandemics?

In the media
25 Aug 2026

Hunting down the last cases of sleeping sickness

Horizon
Pictures of patients waiting at the Mycetoma Research Center in Sudan
Stories
20 Aug 2026

Mycetoma at 10: What recognition made possible

Scientific articles
15 Aug 2026

Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay

International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles
5 Aug 2026

ICH E21: from landmark guidance to specific action for maternal and child health 

Scientific articles
3 Aug 2026

A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms

Infectious Diseases and Therapy
loading
Loading...
Press releases
Press Releases Translations
Press releases
13 May 2020

DNDi short film about new treatment for sleeping sickness awarded Grand Prix at inaugural WHO film festival

Woman living with Chagas disease in Los Angeles
Press releases
14 Apr 2020

Up to 45,000 people living with Chagas disease in the US at risk of severe COVID-19 complications

Woman standing in a street in Colombia
Press releases
13 Apr 2020

Marking World Chagas Day for the first time to help give visibility to this neglected disease

I pledge my support for the COVID-19 Clinical Research Coalition graphic
Press releases
2 Apr 2020

Coalition launched to accelerate research on the prevention and treatment of COVID-19 in low- and middle-income countries

Mother in India with her kids
Press releases
25 Feb 2020

Novartis and DNDi to collaborate on the development of a new oral drug to treat visceral leishmaniasis

Press releases
5 Dec 2019

Brazil’s Ministry of Health and CNPq to invest in researching new treatments for leishmaniasis and Chagas disease

Kids jumping and smiling
Press releases
29 Nov 2019

HIV treatment for children to be produced for under one dollar a day

Adult brugia worms being transferred for testing against various compounds that are being examined in the laboratory.
Press releases
28 Nov 2019

Public-private partnership launched to develop new drugs for roundworm infections

Drug consortium members on stage at the launch in Sao Paulo
Press releases
27 Nov 2019

Research for new drugs against neglected diseases and malaria in Brazil to receive funding boost totaling BRL 43.5 million

Press releases
25 Nov 2019

Efforts to register new hepatitis C treatment in Malaysia receive support from Pharmaniaga

Doctor examining a patient in a hospital
Press releases
25 Nov 2019

DNDi receives $29 million to fast-track the development of drugs to help eliminate sleeping sickness and river blindness

Press releases
20 Nov 2019

Study shows that African eye worm threatens elimination of river blindness

Lab technicians looking into microscope in a clinical working on sleeping sickness
Press releases
30 Oct 2019

Not-for-profit research and development can address deadly market failure for neglected patients, paper shows

Nutritionist explains how to use the 2-in-1 pellets to a mother and her HIV-positive child in Kenya
Press releases
18 Oct 2019

The French development agency AFD renews its support for the Drugs for Neglected Diseases initiative (DNDi) in researching and developing treatments for neglected tropical diseases

Press releases
26 Sep 2019

Lack of awareness of Chagas disease in the US leading to unnecessary deaths in vulnerable immigrant communities

Press releases
15 Sep 2019

La cuvée 2018 de la ‘Vigne des Nations’ de la République et canton de Genève dédiée à DNDi en reconnaissance de son travail auprès des patients les plus négligés

1 2 … 21 ›

Connect and share

Follow us on social media to stay updated and help us share the stories of neglected patients.  

Twitter Facebook Instagram Youtube Linkedin
EN ESPAÑOL
EM PORTUGUÊS
Linkedin-in Instagram Youtube Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license